Getting determined the palmitoylation motif of APLNR, we built a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the development of NCP, which includes pain incidence, microglial activation, and inflammatory component https://whatisconolidine11087.articlesblogger.com/49554696/5-tips-about-block-pain-receptors-with-proleviate-you-can-use-today